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abstract
PURPOSE The purpose of this study was to validate a fully automatic treatment planning system for conventional
radiotherapy of cervical cancer. This system was developed to mitigate staff shortages in low-resource clinics.
METHODS In collaboration with hospitals in South Africa and the United States, we have developed the Radiation
Planning Assistant (RPA), which includes algorithms for automating every step of planning: delineating the body
contour, detecting the marked isocenter, designing the treatment-beam apertures, and optimizing the beam
weights to minimize dose heterogeneity. First, we validated the RPA retrospectively on 150 planning computed
tomography (CT) scans. We then tested it remotely on 14 planning CT scans at two South African hospitals.
Finally, automatically planned treatment beams were clinically deployed at our institution.
RESULTS The automatically and manually delineated body contours agreed well (median mean surface dis-
tance, 0.6 mm; range, 0.4 to 1.9 mm). The automatically and manually detected marked isocenters agreed well
(mean difference, 1.1 mm; range, 0.1 to 2.9 mm). In validating the automatically designed beam apertures, two
physicians, one from our institution and one from a South African partner institution, rated 91% and 88% of
plans acceptable for treatment, respectively. The use of automatically optimized beam weights reduced the
maximum dose significantly (median, −1.9%; P , .001). Of the 14 plans from South Africa, 100% were rated
clinically acceptable. Automatically planned treatment beams have been used for 24 patients with cervical
cancer by physicians at our institution, with edits as needed, and its use is ongoing.
CONCLUSION We found that fully automatic treatment planning is effective for cervical cancer radiotherapy and
may provide a reliable option for low-resource clinics. Prospective studies are ongoing in the United States and
are planned with partner clinics.
J Global Oncol. © 2019 by American Society of Clinical Oncology
Licensed under the Creative Commons Attribution 4.0 License
INTRODUCTION
Global cancer rates are increasing, especially in low-
and middle-income countries.1 By 2025, 20 million
cancer cases are predicted worldwide annually,2 of
which half would benefit from treatment with radiation
therapy.3-5 However, many countries lack adequate
radiation therapy capabilities5; this is due, in part, to
staff shortages in these regions.6 Automating radiation
treatment planning could help mitigate this limitation
by allowing technology to do a large part of the required
work to begin treatment of patients. In addition, an
expedited planning process could enable patients to
be treated much sooner after diagnosis.
According to ASCO and the International Atomic En-
ergy Agency, the recommended treatment of invasive
cervical cancer in low-resource settings is a radio-
therapy technique known as a “four-field box.”7,8 This
technique uses four orthogonal beams to treat the
gross tumor and at-risk tissues in the pelvis. The beam
apertures are based on bony anatomy that is visible in
a digitally reconstructed radiograph from each of the
beam angles: anteroposterior, posteroanterior, right
lateral, and left lateral. Examples of beam apertures
are shown in Figure 1.
Through a collaboration with hospitals in South
Africa and the United States, we have developed
a fully automatic treatment planning tool, the
Radiation Planning Assistant (RPA).9 The RPA
designs patient-specific four-field box radiation
treatments for locally advanced cervical cancer, one
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settings.1 To build the RPA, we developed algorithms to
automate every step in the treatment planning pro-
cess. The RPA has been integrated with a commercial
treatment planning system (TPS) to plan three-
dimensional treatments on planning CT scans with no
human input.
The objective of this study was to validate the individual
algorithms of the RPA and to test the fully integrated system
on patient CT scans. We retrospectively tested the RPA
using patient CT scans from cancer hospitals in the United
States and in South Africa. We have also implemented
a semiautomated version of the RPA into the clinical
workflow at The University of Texas MD Anderson Cancer
Center (Houston, TX; hereafter, MD Anderson).
METHODS
All studies and patient data were handled in accordance
with the corresponding approved institutional review
board protocol, and where required, patient consent was
obtained.
Overview of the RPA
To plan a patient-specific treatment with the RPA, the
following inputs are used: (1) a CT scan of the patient in the
treatment position and (2) a plan order from the physician,
which includes basic patient information, including the
prescription. With no further human input, the RPA au-
tomatically creates a treatment plan that is ready for
physician review, along with plan documentation. This
documentation is for the patient’s medical record and for
performing quality assurance checks that are vital to de-
livering safe radiotherapy.10 The documentation includes
all dose distributions, allowing the physician to review the
quality of the plan, including target coverage.
Algorithms have been developed to automate each manual
step of treatment planning and have been integrated with
the Eclipse TPS (Varian Medical Systems, Palo Alto, CA)
using its Application Programming Interface to form the
fully automatic TPS. The algorithms that automate each
step are described in the following section.
In-House Automation Algorithms
Delineation of the body contour. The body contour (Fig 2) is
important for accurate dose calculation in the Eclipse TPS.
The first step in this algorithm is to identify the location of
the couch using the sum projection signal along the lateral
direction and then searching for the most representative
peak. The couch is then removed from the image by setting
all pixels posterior to this line to the CT number of air. The
RPA then searches for the body contour by thresholding the
CT image intensity (with the couch removed) into a binary
mask; it then uses postprocessing to ensure the topologic
characteristics and smoothness.
Detection of the marked isocenter. The next step in the RPA
is to automatically detect the marked isocenter, as in-
dicated by the intersection of three radiopaque fiducials
placed on the patient’s skin during the planning CT scan
(Fig 2). The RPA automatically detects the marked iso-
center by defining a search domain within the bandwidth of
the body contour. Potential fiducial candidates within the
search domain are identified on the basis of the CT number.
Any false candidates are removed using several criteria,
A
B
FIG 1. Automatically created treatment fields. Beam’s eye view of the (A)
anteroposterior (AP) and (B) right lateral beam angles. The beam apertures
are designed on the basis of the bony anatomy and will be collimated using
the multileaf collimator.
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including size, location, and geometry. Finally, the in-
tersection of the selected cluster of three fiducials is used to
define the marked isocenter.
Design of the treatment field apertures. The RPA then
automatically designs the four orthogonal treatment
beams, which intersect at the marked isocenter. First, the
RPA automatically segments the following bony anatomy
on the CT image: bony pelvis, femoral heads, sacrum,
and fourth and fifth lumbar vertebral bodies. The RPA
uses a deformable, multiatlas technique for automatic
segmentation.11,12 Next, the RPA projects the segmented
anatomy into each beam’s eye view (BEV). The RPA
automatically identifies anatomic landmarks in the BEV,
such as the widest extent of the pelvic inlet, and sets the
beam aperture on the basis of these landmarks according
to a set of defined rules (eg, 2 cm wider than the pelvic
inlet). A representation of this workflow is shown in
Figure 3.
Optimization of the dose distribution. Next, the RPA creates
the treatment beams in the Eclipse TPS using the auto-
matically defined beam apertures set at the automatically
located isocenter. The RPA then automatically calculates
the dose delivered by each beam using 18-MV photons. To
achieve a homogenous dose distribution within the treated
volume, the RPA automatically determines the weighted
contribution of each beam. The RPA uses a least-squares
fitting to determine the beam weights that minimize the
dose heterogeneity inside the treated volume. The treated
volume is defined as the volume intersected by all beams,
contracted by a 0.5-cm margin to exclude the rapid dose
drop-off at the field edge.
Retrospective Testing of RPA Algorithms
We first tested each algorithm retrospectively on 150 pelvic
CT scans of female patients at MD Anderson. Then we
tested the fully integrated RPA on 10 CT scans of female
patients from Tygerberg Hospital (Cape Town, South Africa)
and four CT scans from Groote Schuur Hospital (Cape
Town, South Africa). All CT scans had been acquired for
radiotherapy planning, with the patients supine.
Delineation of the body contour. The automatically de-
lineated body contour from the RPA was compared with the
body contour resulting from Eclipse’s semiautomated
body contour tool, with manual edits where necessary.
The two body contours were compared quantitatively
using the Dice similarity coefficient, mean surface dis-
tance, and Hausdorff distance.11
A B C
FIG 2. Body contour and marked isocenter. (A-C) Three views, (A) axial, (B) sagittal, and (C) coronal, of the
computed tomography scan of a patient. The automatically segmented body contour is outlined in red. The views
intersect at the location of the marked isocenter (green), which is determined on the basis of the radiopaque


















FIG 3. Workflow of the algorithm that automatically designs four-field box treatment beams. For automated planning, the only input is a computed
tomography scan and a prescription. No other human input is required, and a plan is presented for physician review. 2D, two dimensional; 3D, three
dimensional; BEV, beam’s eye view
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Detection of the marked isocenter. The automatically lo-
calized marked isocenter was compared with an isocenter
that had been manually placed at the intersection of the
three fiducial markers. The absolute distance between
these two points was calculated and used for comparison.
Design of the treatment-field apertures. The automatically
created treatment-field apertures were reviewed by two
physicians specializing in gynecologic radiation oncology,
one from MD Anderson (A.J.) and one from Tygerberg
Hospital in South Africa (H.S.). They rated each field as
“acceptable” or “not acceptable” for treatment, on the
basis of whether they would treat the patient using that
field. For a plan to be acceptable, all four fields must have
been rated as acceptable.
Optimization of the dose distribution. The dose distributions
were calculated using automatically optimized beam
weights and were compared with nonoptimized dose dis-
tributions, which used equally weighted beams (ie, each
beam contributed the same dose to the calculation point).
The maximum dose, defined by the hottest 1 cc of tissue,
was evaluated. We also assessed the coverage, defined by
the percentage of the treated volume covered by at least
95% of the prescription dose. The values with and without
automated beam weight optimization were compared using
a Wilcoxon signed-rank test.
Running time of the RPA system. The time for the RPA to
automatically plan a treatment was recorded. This included
every step, beginning from the import of the CT scan and
plan order into the RPA and ending with the optimized and
calculated treatment plan in the TPS, ready for physician
review.
Running the RPA remotely on patients at two South African
hospitals. The fully integrated RPA was tested on-site at
Tygerberg Hospital and Groote Schuur Hospital. The
resulting treatment plans and dose distributions were
reviewed by physicians specializing in gynecologic oncology
at the corresponding hospital (H.S., N.F.) and rated as
acceptable or not acceptable for treatment.
Clinical Deployment at MD Anderson
A semiautomated version of the RPA was created and
deployed into the clinical workflow at MD Anderson for
patients with cervical cancer in July 2016. This version was
integrated with the Pinnacle TPS (Philips Healthcare,
Andover, MA). The workflow of this system differs from the
fully automated workflow in that the physician manually
contours the soft-tissue target volumes on the CT scan.
After the CT scan is imported into the TPS, the dosimetrist
exports the CT scan to the RPA, The RPA then automat-
ically detects the marked isocenter and designs the
treatment-field apertures (still based on the bony anatomy).
Once complete, the RPA automatically sends an e-mail
indicating that the plan is ready, and the dosimetrist imports
the uncalculated treatment beams. The physician reviews
the beams, making any necessary edits on the basis of the
contours of the target and critical structures, and planning
continues.
We assessed any manual changes to the location of the
marked isocenter. We also quantitatively compared the
extent of the physician edits to the automatically planned
beam apertures, using the mean surface distance and
Hausdorff distance.
RESULTS
Retrospective Testing of RPA Algorithms
Delineation of the body contour. A typical result of the
automatically delineated body contour is shown in Figure 2.
This body contour agreed well with the contour generated
using Eclipse’s semiautomatic tool with manual edits. The
median Dice similarity coefficient was 0.996 (standard
deviation [SD], 0.001; range, 0.988 to 0.997). The median
mean surface distance was 0.6 (SD, 0.2; range, 0.4 to 1.9)
mm. The median Hausdorff distance was 22.3 (SD, 18.6;
range, 5.7 to 122.7) mm.
The largest discrepancies were found when the patient’s
arm was included in only one of the contours. Although
these differences may seem large in some patients, they
result from differences in how each technique handled the
inclusion of the patients’ arms. These discrepancies are
outside the treatment area and would not affect the dose
delivered.
Detection of the marked isocenter. The distances between
automatically andmanually placedmarked isocenters were
small (average, 1.1 mm; SD, 0.7; range, 0.1 to 2.9 mm).
The largest discrepancies were found when the fiducials
did not all appear on the same axial slice of the patient’s CT
scan. This sometimes led to the isocenters being located on
adjacent slices.
Design of the treatment-field apertures. An example of the
treatment fields generated by the RPA are shown in
Figure 1. Of the 150 treatment plans (n = 600 fields), one
physician rated 136 (91%) as acceptable for treatment.
The second physician found that the image quality of the
BEV was too poor in six of 150 plans (four had large
amounts of bowel contrast that partially obstructed the bony
anatomy in the BEV) and did not rate these six plans. Of the
remaining 144 plans, the physician rated 126 (88%) as
acceptable. Of the plans marked as unacceptable by at
least one physician (n = 23), 19 (83%) had incorrectly
placed superior borders as a result of inaccurate contouring
of the vertebral bodies during the automatic segmentation
step. To overcome this, we will incorporate an option to
manually adjust this border in the workspace of the RPA
where the physician reviews the treatment plan.
Optimization of the dose distribution. Figure 4 shows
a comparison of the maximum dose for each patient with
automatic beam-weight optimization versus without opti-
mization. The maximum dose was significantly lower using
automatically optimized beam weights, with a median
Kisling et al
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change of −1.9% (P , 0.001, range −10.0% to +0.4%).
In addition, there was a small yet statistically significant
increase in the coverage of the treated volume. The
median percentage of the volume covered by 95% of the
prescription increased by 0.6% (P , .001, range: −2.8%
to +2.8%).
The use of automatic beam-weight optimization was es-
pecially beneficial for patients with high maximum dose
(≥ 107% of the prescription dose) without optimization.
These patients’ plans experienced a larger median change
in maximum dose (−3.5%). Furthermore, the percentage of
patients with high maximum doses was reduced from 44%
without optimization to 3% with optimization. Figure 5
shows the dose distribution of one axial slice from one
patient whose very high maximum dose was greatly re-
duced using optimized beam weights.
Running time of the RPA system. Once the planning CT
scan and plan order were imported, the fully integrated
RPA created a plan in Eclipse ready for physician review in
a median of 11.0 minutes (range, 8.2 to 13.6 minutes).
Running the RPA remotely in patients at two South African
hospitals. Of the 14 treatment plans created on the
planning CT scans of patients from the partner hospitals in
South Africa, 100% were approved for treatment by the
physician (10 plans from Tygerberg Hospital and four from
Groote Schuur Hospital).
Clinical Deployment at MD Anderson
Since the clinical version of the RPA was deployed at MD
Anderson, it has been used in the planning of 24 patients
with cervical cancer. The location of the marked isocenter
was not adjusted for 20 patients and was adjusted less than
1 mm for four patients. The physicians edited the auto-
matically created treatment fields on the basis of their
contours of the target and normal tissues. When comparing
the fields before and after physician edits, the median
mean surface distance was 3.5 mm (SD, 2.4 mm; range,
0.0 to 10.4 mm) and the median Hausdorff distance was
13.9 (SD, 9.1; range, 0.0 to 42.0) mm.
DISCUSSION
In this work, we validated the RPA’s algorithms with phy-
sician review of a large cohort of patients and performed
remote testing of the fully integrated RPA. This work rep-
resents a critical step before implementation of the fully
automated system in the clinic. To our knowledge, this is
the first work toward automated treatment planning for
radiation therapy of cervical cancer.
Before this study, the algorithms for defining the beam
apertures were honed over several testing iterations on
more than 250 patient CT scans with feedback from
physicians at MD Anderson and Tygerberg Hospital and on
the basis of the clinical edits made by physicians using the
MD Anderson–deployed version of the RPA. The final al-
gorithm, validated in this study, was a consensus of the
radiation oncologists for patients whose disease extent was
limited to the upper two-thirds of the vagina and with only
pelvic lymph node involvement. In the future, we can ex-
tend this work for patients with more advanced disease (eg,
involvement of the distal vagina or paraaortic nodes) by
including variations on the beam-aperture definitions.
Within the RPA workflow, the rules by which the beam
apertures are defined can be adjusted for a range of dis-
ease stages, as long as these rules are based on auto-
matically segmented bony anatomy.
In addition to extensive retrospective testing at MD
Anderson, we conducted a successful retrospective test of
remote, fully automatic treatment planning at two clinics in
South Africa. Moving forward, we will prepare for clinical
deployment and testing, beginning with our two partner
clinics in South Africa. We will monitor the prospective use
of the RPA and evaluate its effect on clinical workflow,
including the time staff spend planning and the time from
CT simulation to first treatment. During this testing, we
expect to address challenges on the basis of differences in
clinical workflow and software and hardware platforms.
Ultimately, our goal is to deploy in clinics with fewer re-
sources, which will likely introduce new challenges in terms
of staffing, workflow, and equipment. We also are evalu-
ating options to make this tool accessible to low-resource
clinics, considering that there may be limited financial
resources available. In addition, we are developing
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FIG 4. Maximum dose was reduced using automatic beam-weight
optimization. The maximum dose (hottest 1 cc) is shown for each
patient (n = 149) as a percentage of the prescription dose for opti-
mized versus equal beam weights (nonoptimized). The dotted line
represents no change in the maximum dose, and all points below this
line showed a reduction in the maximum dose. The reduction was
especially large for patients who had very high maximum doses using
equal beam weights.
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automated treatment planning for head-and-neck cancer
radiation therapy13 and postmastectomy chest-wall radia-
tion therapy.9
The treatment technique planned by the RPA is recom-
mended for cervical cancer in low-resource clinics,
according to the International Atomic Energy Agency and
ASCO.7,8 Although treatment apertures on the basis of
soft-tissue contours would be preferable for curative
treatments, the bony anatomy approach is used as an
alternative in low-resource settings where there is a lack of
staff to complete the manual contouring necessary for
more conformal treatments. With plans created by the
RPA, the physician can use the automatically created
documentation to review the dose distribution and eval-
uate the plan’s coverage, even without having contoured
the soft-tissue disease.
Given the prevalence of cervical cancer, the fully automatic
treatment planning offered by the RPA could help alleviate
staff shortages in low-resource clinics. In addition, by re-
ducing the back-and-forth handoffs between planners and
physicians needed to manually plan a treatment, the au-
tomated system could prepare a plan more quickly, pre-
senting a plan for review shortly after the CT scan is
acquired. We envision the RPA facilitating same-day
treatments, where a patient never has to leave the clinic
between CT scan and her first treatment. In contrast, for
patients with gynecologic pelvic disease in our clinical
practice, the median planning time is 21 hours (inter-
quartile range, 7 to 47 hours) from CT simulation to when
the plan is ready for physician review, including handoffs
and time when the plan is not being actively worked on
(unpublished data). Furthermore, handoffs between staff
have been identified as a weakness in radiotherapy safety,
and any reduction in the number of handoffs may result in
an improvement in the safety of radiation therapy.14,15
The results of this study indicate that fully automatic
treatment planning for cervical cancer is achievable. More
prospective studies are necessary and are ongoing in the
United States and planned with our international partner
clinics. By reducing the work required by trained staff, the
RPA could ease the burden of creating patient-specific
treatment plans in resource-constrained clinics. As a result,
using the RPA to automatically plan treatments could help
reduce some of the barriers to establishing radiation
therapy programs.
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FIG 5. Patient plans with high maximum doses experience a substantial
reduction in the maximum dose with automatic beam-weight optimization.
The resulting dose distribution for an (A) automatically planned four-field
box with equal beam weights (nonoptimized) and (B) automatically opti-
mized beam weights. The maximum dose was reduced from 117% to
107% of the prescription dose for this patient.
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